Literature DB >> 8418032

Immunoglobulin M and G antibody responses to Plasmodium falciparum glutamate-rich protein: correlation with clinical immunity in Gambian children.

M Dziegiel1, P Rowe, S Bennett, S J Allen, O Olerup, A Gottschau, M Borre, E M Riley.   

Abstract

The aims of the present study were to describe the age-related immunoglobulin M (IgM) and IgG response to part of a 220-kDa glutamate-rich protein (GLURP) from Plasmodium falciparum and to determine possible correlations of possession of these antibodies with malaria morbidity. IgM and IgG levels were measured with a recombinant fusion protein consisting of the carboxy-terminal 783 amino acids of the GLURP. Samples for the study were obtained during a longitudinal malaria morbidity survey performed in The Gambia; cross-sectional surveys were performed at the beginning of the transmission season in May and in October. Seropositivity rates increased with age to a maximum of 77% for IgM and 95% for IgG in adults. High prevalences of seropositivity were associated with certain human leukocyte antigen class II alleles (DRw8, DR9, DR7, DR4, DQw7, and DQw2) or haplotypes. The relationship between anti-GLURP489-1271 antibodies and clinical immunity is not clear; asymptomatically infected children aged 5 to 8 years had significantly higher levels of IgG than clinically ill children of the same age, suggesting that antibodies to the carboxy-terminal part of the GLURP may contribute to immunity to P. falciparum. However, this was not significant for younger children.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8418032      PMCID: PMC302693          DOI: 10.1128/iai.61.1.103-108.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  Recombinant Plasmodium falciparum glutamate rich protein; purification and use in enzyme-linked immunosorbent assay.

Authors:  M Dziegiel; M B Borre; S Jepsen; B Hogh; E Petersen; J Vuust
Journal:  Am J Trop Med Hyg       Date:  1991-03       Impact factor: 2.345

2.  Primary structure and localization of a conserved immunogenic Plasmodium falciparum glutamate rich protein (GLURP) expressed in both the preerythrocytic and erythrocytic stages of the vertebrate life cycle.

Authors:  M B Borre; M Dziegiel; B Høgh; E Petersen; K Rieneck; E Riley; J F Meis; M Aikawa; K Nakamura; M Harada
Journal:  Mol Biochem Parasitol       Date:  1991-11       Impact factor: 1.759

3.  HLA-DR-DQ haplotypes defined by restriction fragment analysis. Correlation to serology.

Authors:  B Carlsson; J Wallin; J Böhme; E Möller
Journal:  Hum Immunol       Date:  1987-10       Impact factor: 2.850

4.  Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa.

Authors:  B M Greenwood; A K Bradley; A M Greenwood; P Byass; K Jammeh; K Marsh; S Tulloch; F S Oldfield; R Hayes
Journal:  Trans R Soc Trop Med Hyg       Date:  1987       Impact factor: 2.184

5.  Antibodies to a recombinant glutamate-rich Plasmodium falciparum protein: evidence for protection of individuals living in a holoendemic area of Liberia.

Authors:  B Hogh; E Petersen; M Dziegiel; K David; A Hanson; M Borre; A Holm; J Vuust; S Jepsen
Journal:  Am J Trop Med Hyg       Date:  1992-03       Impact factor: 2.345

6.  Branhamella catarrhalis: antigenic determinants and the development of the IgG subclass response in childhood.

Authors:  D Goldblatt; M W Turner; R J Levinsky
Journal:  J Infect Dis       Date:  1990-11       Impact factor: 5.226

7.  Recognition of dominant T cell-stimulating epitopes from the circumsporozoite protein of Plasmodium falciparum and relationship to malaria morbidity in Gambian children.

Authors:  E M Riley; S J Allen; S Bennett; P J Thomas; A O'Donnell; S W Lindsay; M F Good; B M Greenwood
Journal:  Trans R Soc Trop Med Hyg       Date:  1990 Sep-Oct       Impact factor: 2.184

8.  Immune sera recognize on erythrocytes Plasmodium falciparum antigen composed of repeated amino acid sequences.

Authors:  R L Coppel; A F Cowman; R F Anders; A E Bianco; R B Saint; K R Lingelbach; D J Kemp; G V Brown
Journal:  Nature       Date:  1984 Aug 30-Sep 5       Impact factor: 49.962

9.  Association between immune recognition of the malaria vaccine candidate antigen Pf155/RESA and resistance to clinical disease: a prospective study in a malaria-endemic region of west Africa.

Authors:  E M Riley; S J Allen; M Troye-Blomberg; S Bennett; H Perlmann; G Andersson; L Smedman; P Perlmann; B M Greenwood
Journal:  Trans R Soc Trop Med Hyg       Date:  1991 Jul-Aug       Impact factor: 2.184

10.  Antibodies in malarial sera to parasite antigens in the membrane of erythrocytes infected with early asexual stages of Plasmodium falciparum.

Authors:  H Perlmann; K Berzins; M Wahlgren; J Carlsson; A Björkman; M E Patarroyo; P Perlmann
Journal:  J Exp Med       Date:  1984-06-01       Impact factor: 14.307

View more
  19 in total

1.  Interaction of HLA and age on levels of antibody to Plasmodium falciparum rhoptry-associated proteins 1 and 2.

Authors:  A Johnson; R Leke; L Harun; C Ginsberg; J Ngogang; A Stowers; A Saul; I A Quakyi
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

2.  The glutamate-rich protein (GLURP) of Plasmodium falciparum is a target for antibody-dependent monocyte-mediated inhibition of parasite growth in vitro.

Authors:  M Theisen; S Soe; C Oeuvray; A W Thomas; J Vuust; S Danielsen; S Jepsen; P Druilhe
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

3.  Naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs48/45 and Pfs230 in an area of seasonal transmission.

Authors:  André Lin Ouédraogo; Will Roeffen; Adrian J F Luty; Sake J de Vlas; Issa Nebie; Edith Ilboudo-Sanogo; Nadine Cuzin-Ouattara; Karina Teleen; Alfred B Tiono; Sodiomon Bienvenu Sirima; Jan-Peter Verhave; Teun Bousema; Robert Sauerwein
Journal:  Infect Immun       Date:  2011-10-03       Impact factor: 3.441

4.  Hemoglobin S and C heterozygosity enhances neither the magnitude nor breadth of antibody responses to a diverse array of Plasmodium falciparum antigens.

Authors:  Xiaolin Tan; Boubacar Traore; Kassoum Kayentao; Aissata Ongoiba; Safiatou Doumbo; Michael Waisberg; Ogobara K Doumbo; Philip L Felgner; Rick M Fairhurst; Peter D Crompton
Journal:  J Infect Dis       Date:  2011-10-12       Impact factor: 5.226

5.  Cytophilic immunoglobulin responses to Plasmodium falciparum glutamate-rich protein are correlated with protection against clinical malaria in Dielmo, Senegal.

Authors:  C Oeuvray; M Theisen; C Rogier; J F Trape; S Jepsen; P Druilhe
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

6.  Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein.

Authors:  Soe Soe; Michael Theisen; Christian Roussilhon; Khin-Saw Aye; Pierre Druilhe
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

7.  Immunogenicity of the Plasmodium falciparum glutamate-rich protein expressed by vaccinia virus.

Authors:  M Theisen; G Cox; B Høgh; S Jepsen; J Vuust
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

8.  Antigenicity and immunogenicity of recombinant glutamate-rich protein of Plasmodium falciparum expressed in Escherichia coli.

Authors:  M Theisen; J Vuust; A Gottschau; S Jepsen; B Høgh
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

Review 9.  The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis.

Authors:  Freya J I Fowkes; Jack S Richards; Julie A Simpson; James G Beeson
Journal:  PLoS Med       Date:  2010-01-19       Impact factor: 11.069

10.  How Should Antibodies against P. falciparum Merozoite Antigens Be Measured?

Authors:  Sriwipa Chuangchaiya; Kristina E M Persson
Journal:  J Trop Med       Date:  2013-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.